is semaglutide going off the market Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s Semaglutide shortage ends as FDA

Yet LifeVantage promotional materials and distributor pitches tend to spin these results positively

It inhibits amyloid-beta plaque accumulation in Alzheimers disease (AD) and enhances cognitive function by activating sirtuins (e.g., SIRT1) and modulating AMPK/NF-B pathways (23)

Overall, the benefits of GLP-1 agonists in terms of weight loss and improved metabolic health generally outweigh the potential risks, particularly when used under the guidance of a healthcare professional

Low-purity or degraded peptide produces poor results regardless of protocol

While these natural alternatives can be beneficial, GLP-1 supplements may provide a more sustained elevation of GLP-1 levels compared to dietary changes alone